Notice Number: NOT-DA-16-031
Key Dates
Release Date: May 11, 2016
Related Announcements
Issued by
National Institute on Drug Abuse (NIDA)
Purpose
The purpose of this Notice is to update the Application Types Allowed information in PA-16-145 "Role of Astrocytes and Astrocytic Networks in Drug Abuse (R21)."
Part 2. Section II. Award Information
Current Text:
Application Types Allowed
|
New |
New Text:
Application Types Allowed
|
New The OER Glossary and the SF424 (R&R) Application Guide provide details on these application types. |
Part 2. Section V. Application Review Information
1. Criteria
Current Text:
Resubmissions
Not Applicable
Renewals
Not Applicable
Revisions
Not Applicable
New Text:
Resubmissions
For Resubmissions, the committee will evaluate the application as now presented, taking into consideration the responses to comments from the previous scientific review group and changes made to the project.
Renewals
Not Applicable
Revisions
For Revisions, the committee will consider the appropriateness of the proposed expansion of the scope of the project. If the Revision application relates to a specific line of investigation presented in the original application that was not recommended for approval by the committee, then the committee will consider whether the responses to comments from the previous scientific review group are adequate and whether substantial changes are clearly evident.
All other aspects of this FOA remain unchanged.
Inquiries
Please direct all inquiries to:
Roger G Sorensen, Ph.D., MPA
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-3205
Email: [email protected]
and Human Services (HHS)
